Loading…
Portfolio as on May 2026 · 54 equity positions
Kotak Manufacture In India Fund is a Equity (Diversified) scheme managed by Kotak MF Mutual Fund. As of disclosures dated May 2026, the scheme holds 54 equity positions with an estimated equity AUM of ₹₹2,650 Cr. The portfolio is anchored by its top conviction bet on Sun Pharmaceutical Industries, which commands a weight of 4.59%of the fund's total assets.
From a sector allocation perspective, the fund managers have concentrated their largest bet on Pharmaceuticals & Biotechnology, representing 15.76% of the equity portfolio. This is followed by Automobiles (15.69%) and Industrial Products (10.77%). Under SEBI's guidelines and based on its underlying assets, this scheme carries a Very High Risk risk classification.
₹22.33 per unit +11.5% vs Jul '25
Last 365 days · daily NAV from AMFI · Kotak Manufacture In India Fund
Based on ~11 months of weekly NAV history from AMFI. Volatility is the annualized standard deviation of NAV returns. Sharpe ratio assumes a 6.5% risk-free rate. Past performance does not guarantee future returns — not investment advice.
Top 10 holdings make up 36.1% of the portfolio · top 5 = 20.9%.
Equity holdings only, ISIN-verified, from Kotak Mahindra Mutual Fund's public monthly portfolio disclosure (May 2026). Not investment advice.
Weight = the position as a % of this fund's portfolio. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).